These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3376954)

  • 1. Comments on the article by Castleman and Ziem.
    Djuric D
    Am J Ind Med; 1988; 13(5):613-4. PubMed ID: 3376954
    [No Abstract]   [Full Text] [Related]  

  • 2. Corporate influence on threshold limit values by Castleman and Ziem.
    Frank AL
    Am J Ind Med; 1988; 13(5):607-8. PubMed ID: 3376951
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance and use of threshold limit values with reference to "Corporate Influence on Threshold Limit Values" by Castleman and Ziem.
    Tsuchiya K
    Am J Ind Med; 1988; 14(2):215-6. PubMed ID: 3207108
    [No Abstract]   [Full Text] [Related]  

  • 4. TLVs--what now?
    Muir DC
    Am J Ind Med; 1988; 13(5):605-6. PubMed ID: 3376950
    [No Abstract]   [Full Text] [Related]  

  • 5. Credibility in the TLV process.
    Abrams HK
    Am J Ind Med; 1988; 13(5):609-10. PubMed ID: 3376952
    [No Abstract]   [Full Text] [Related]  

  • 6. Quis Custodiet ipsos Custodes (Juvenal, 98 A.D.).
    Lerman Y
    Am J Ind Med; 1988; 13(5):621-2. PubMed ID: 3376958
    [No Abstract]   [Full Text] [Related]  

  • 7. TLVs--a personal opinion.
    Dror K
    Am J Ind Med; 1988; 13(5):617-8. PubMed ID: 3376956
    [No Abstract]   [Full Text] [Related]  

  • 8. Corporate influence on threshold limit values.
    Davis JM
    Am J Ind Med; 1988; 13(5):615. PubMed ID: 3376955
    [No Abstract]   [Full Text] [Related]  

  • 9. Standard setting.
    Duncan KP
    Am J Ind Med; 1988; 13(5):619-20. PubMed ID: 3376957
    [No Abstract]   [Full Text] [Related]  

  • 10. Time to reconsider TLVs.
    Djerassi L
    Am J Ind Med; 1988; 13(5):611-2. PubMed ID: 3376953
    [No Abstract]   [Full Text] [Related]  

  • 11. On "Corporate influence on threshold limit values" by Castleman and Ziem.
    Richter ED
    Am J Ind Med; 1988; 14(3):365-8. PubMed ID: 3189353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Maximum permissible concentration of toxic substances in biological materials].
    Durić D
    Nar Zdrav; 1971 Sep; 27(9):329-32. PubMed ID: 5155791
    [No Abstract]   [Full Text] [Related]  

  • 13. Threshold limit values: a balanced report.
    Cox GV
    Am J Ind Med; 1988; 14(2):233-4. PubMed ID: 3207112
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent achievements and research initiated in the Swedish plastics and rubber industry.
    Englund A; Holmberg B
    Environ Health Perspect; 1976 Oct; 17():237-9. PubMed ID: 1026411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upgrading occupational epidemiology and standard setting by improved exposure monitoring.
    Vanhoorne M
    Am J Ind Med; 1988; 14(6):733-4. PubMed ID: 3232690
    [No Abstract]   [Full Text] [Related]  

  • 16. Reflections on the problem of reliability in occupational and environmental toxicology.
    Silbergeld EK
    Am J Ind Med; 1988; 13(5):601-3. PubMed ID: 3376949
    [No Abstract]   [Full Text] [Related]  

  • 17. Corporate influence on threshold limit values.
    Castleman BI; Ziem GE
    Am J Ind Med; 1988; 13(5):531-59. PubMed ID: 3287906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audiometry in industry.
    Br Med J; 1978 Aug; 2(6134):380. PubMed ID: 687931
    [No Abstract]   [Full Text] [Related]  

  • 19. Swedish occupational exposure limits: developments in scientific evaluation and documentation.
    Nordberg GF; Frostling H; Lundberg P; Westerholm P
    Am J Ind Med; 1988; 14(2):217-21. PubMed ID: 3207109
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety: applying TLVs.
    Hartley C
    Occup Health (Lond); 1980 Jun; 32(6):301-3. PubMed ID: 6902143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.